Indaptus Therapeutics Inc (INDP): Total Asset Value of Company
Indaptus Therapeutics (INDP) is developing innovative non-pathogenic bacterial systems (including decOyp) to combat tumors, leveraging clinical trial results and M&A potential. The use of inactivated bacteria provides the company with patent protection and pricing power within the oncology sector. The share price retrospective demonstrates total assets at 9.41, while demand for such immunotherapeutic platforms is currently being shaped through clinical testing.
Comprehensive metric breakdowns and analytics for Indaptus (INDP)
- price and consensus price forecast:
- market capitalization data:
- book capitalization data:
- debt and liquidity data:
All Debt to Shareholders' Equity Ratio Indaptus Therapeutics|INDP - Long-Term Debt to Equity|Short-Term Debt to Equity Ratio Indaptus Corp|INDP - Company Aggregate Debts|Debts to Book Capitalization Indaptus Corp|INDP - Company Long-Term Liabilities|Company Short-Term Loans and Borrowings Indaptus Therapeutics
Fundamental valuation:INDP, indaptusrx.com
Total assets represent the aggregate of the company's resources, calculated reverse-engineered through return on assets (ROA) to identify hidden business degradation, while analyzing the organization's asset volume allows for an assessment of balance sheet stability against a critically short cash runway and high safety risks associated with the early-phase trials of Indaptus Therapeutics (INDP) anti-tumor platforms.
Competitors of Indaptus Therapeutics (INDP)
ARGX (argenx.com) - Total Asset Value of Company|Aggregate Company Assets BioNTech BNTX|Total Asset Value of Company Abivax|ADMA Bio (ADMA) - Company Total Assets|Aggregate Asset Value Protagonist Corp (PTGX)|Company Total Assets IMVT (Immunovant, Inc.)|kiniksa.com - Company Total Assets|Aggregate Company Assets Grifols (GRFS)|ADPT: Aggregate Asset Value|CLDX (Celldex) - Aggregate Company Assets|Aurinia Corp (AUPH) - Cumulative Company Assets|BCRX (BioCryst) - Company Total Assets|Company Total Assets veratx.com (VERA)|Dianthus Therapeutics, Inc. (DNTH) - Cumulative Company Assets|Aggregate Asset Value Pharvaris NV (PHVS)|Company Total Assets ABCL|Tourmaline - Company Total Asset Base|PGEN: Aggregate Company Assets|PHAR: Cumulative Company Assets|NKTR (Nektar Therapeutics Inc.) - Aggregate Company Assets|Cumulative Company Assets Upstream Bio, Inc.|ZBIO (Zenas Biopharma, Inc.) - Cumulative Company Assets|Company Total Assets IMNM|Aggregate Company Assets Gossamer Bio, Inc. GOSS|Total Business Assets kalvista.com (KALV)|SEPN: Company Total Assets|Company Assets Pieris Pharma PVLA|Company Total Assets SVRA (Savara Corp)|RIGL: Company Total Asset Base|Aggregate Company Assets AnaptysBio, Inc.|astriatx.com (ATXS) - Total Business Assets|Company Total Assets enGene (ENGN)|Total Business Assets RAPT Therapeutics Inc.|Company Total Assets JBIO|Company Total Assets ACRS (Aclaris Therapeutics, Inc)|Kyverna Therapeutics (KYTX) - Aggregate Company Assets|TLSA - Total Asset Value of Company|Cumulative Company Assets Cabaletta Bio CABA|Ventyx Biosciences Inc. (VTYX) - Aggregate Business Assets|THTX: Cumulative Company Assets|AVTX (Avalo Therapeutics Inc) - Company Total Assets|ELDN: Aggregate Company Assets|Company Total Asset Base agenusbio.com (AGEN)|Climb Bio (CLYM) - Cumulative Company Assets|Aggregate Asset Value Zura Bio Ltd ZURA|Cumulative Company Assets aTyr (ATYR)|Aggregate Business Assets Adagene Inc ADAG|Company Total Assets Ikena Oncology, Inc. (IMA)|STTK - Aggregate Asset Value|Company Total Assets EQ|CNTB (Connect Biopharma Holdings Limited) - Company Assets|IMUX - Aggregate Company Assets|Aggregate Asset Value Atara Biotherapeutics Inc|Company Total Assets IFRX|Company Total Assets XFOR (x4pharma.com)|Adicet Bio, Inc. (ACET) - Aggregate Company Assets|Total Asset Value of Company Celularity Inc CELU|INMB (INmune Bio Corp) - Company Total Assets|Barinthus Biotherapeutics Corp (BRNS) - Company Assets|KZR: Cumulative Company Assets|Company Total Assets sabbiotherapeutics.com|Akari Therapeutics Plc (AKTX) - Cumulative Company Assets|Aggregate Business Assets Enlivex Therapeutics, Ltd.|QTTB (Q32 Bio Inc.) - Company Total Assets|Company Total Asset Base GeoVax Corp (GOVX)|Edesa Biotech, Inc. - Company Total Assets|ibioinc.com - Cumulative Company Assets|Aggregate Company Assets CARM (Carisma Tx)|XTLB - Company Total Asset Base|boltbio.com - Company Total Assets|HCWB (HCW Biologics) - Company Total Asset Base|Aggregate Company Assets Aptevo Therapeutics, Inc. (APVO)|Total Business Assets AIM ImmunoTech, Inc.|Company Total Assets Aditxt ADTX|Total Business Assets GRI (GRI Bio Inc)|XORTX (XRTX) - Aggregate Company Assets|Vyome Therapeutics - Total Asset Value of Company|Aggregate Company Assets Revelation Biosciences|SCNI - Total Asset Value of Company|Company Total Assets calcimedica.com CALI|Affimed N.V. (AFMD) - Aggregate Asset Value|ALLK (Allakos Inc) - Company Total Assets|Company Total Assets HOOK|IGM Biosciences, Inc. (IGMS) - Aggregate Company Assets|Aggregate Asset Value ITOS (iteostherapeutics.com)|Ocean Biomedical - Aggregate Company Assets|Cumulative Company Assets TC BioPharm (Holdings) Plc TCBP|Third Harmonic Bio, Inc - Company Total Assets